Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net loss	$ (14,594)	$ (92,690)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation, amortization and accretion	6,699	7,926
Impairment expense	2,600	64,649
Stock-based compensation expense	5,146	4,018
(Gain) loss on derivative warrant liabilities	(6,167)	7
Gain from contingent consideration	(504)	(682)
Amortization of senior debt (premium) discount	413	(268)
(Gain) on sale of equipment	(42)	(44)
Gain on extinguishment of debt		(193)
Inventory write-down	199	352
Other noncash adjustments	13	(152)
Changes in operating assets and liabilities:
Accounts receivable	(12,335)	647
Inventories	(2,987)	91
Prepaid expenses and other current assets	(3,603)	1,406
Accounts payable and other	3,720	(8,099)
Accrued liabilities	7,031	1,252
Other operating assets and liabilities, net	(83)	52
Net cash used in operating activities	(14,494)	(21,728)
Investing Activities
Contingent consideration payment		(3,138)
Other investing activities	38	(69)
Net cash provided by (used in) investing activities	38	(3,207)
Financing Activities
Proceeds from issuance of stock and warrants	13,012	12,700
Payment of stock issuance costs	(1,045)	(782)
Payment made to fixed payment arrangement	(4,117)	(3,277)
Payments made to borrowings	(73)	(16,075)
Proceeds from borrowings		15,000
Payment for debt issuance costs	(92)	(363)
Net proceeds received (payments made on) short-term line of credit	6,590	(4,549)
Other financing activities		(7)
Net cash provided by financing activities	14,275	2,647
Net change in cash, cash equivalents and restricted cash	(181)	(22,288)
Cash, cash equivalents and restricted cash at beginning of period	19,360	49,901
Cash and cash equivalents at end of period	19,179	27,613
Supplemental cash flow data
Cash paid for interest	$ 2,861	3,080
Non-cash investing and financing activities:
Other noncash investing and financing activities		$ 473